mwymwAbstract:Tuberculosis, is a contagious respiratory condition caused by infection with the bacterium Mycobacterium tuberculosis. With the rapid prevalence of COVID-19, the multifaceted public health interventions, including non-pharmaceutical measures have been conducted. Results showed that the public health policies implemented by China during the COVID-19 outbreak have had a positive impact on controlling the development of tuberculosis. This paper explores the interplay between tuberculosis (TB) control and the public health measures implemented during the COVID-19 pandemic in China. It highlights how non-pharmaceutical interventions (NPIs) such as travel restrictions, social distancing, mask-wearing, and early case detection, initially designed to contain COVID-19, also contributed to reducing TB transmission. Additionally, the rapid development of China’s public health infrastructure and the use of digital technologies during the pandemic enhanced TB surveillance, diagnosis, and treatment adherence. Key interventions included electronic patient service systems, digital adherence technologies (DATs), and integrated digital platforms that improved treatment outcomes. However, challenges such as reduced TB notifications during COVID-19 and financial constraints in TB management were identified. The paper emphasizes the importance of policy adaptations, technological innovations, and sustainable healthcare reforms to address TB in a post-pandemic world. China’s experience provides valuable insights for future infectious disease control, demonstrating how coordinated public health strategies can effectively manage multiple health challenges simultaneously.
